imatinib mesylate has been researched along with Cancer of Endometrium in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bono, Y; Fujiwara, H; Kyo, S; Maida, Y; Mizumoto, Y; Nakamura, M; Takakura, M; Zhang, X | 1 |
Agorastos, T; Bontis, J; Theodoridis, TD; Venizelos, ID; Zafrakas, M; Zepiridis, L | 1 |
Cho, JH; Hur, M; Kim, WS; Ko, YS; Lee, MH; Moon, HW; Yun, YM | 1 |
Broaddus, RR; Burke, TW; Gershenson, DM; Lu, KH; Oh, JC; Ramondetta, LM; Schmandt, R; Slomovitz, BM; Wu, W | 1 |
Ban, S; Fujimura, M; Hirose, T; Ishihara, O; Mitsuhashi, T; Nakayama, M; Ogawa, F; Sakurai, S; Shimizu, M; Shimizu, Y | 1 |
Bauerschlag, DO; Hilpert, F; Jonat, W; Maass, N; Meinhold-Heerlein, I; Mundhenke, C; Roesel, F; Schem, C; Sturner, KH; Weigel, MT | 1 |
2 review(s) available for imatinib mesylate and Cancer of Endometrium
Article | Year |
---|---|
KIT protein expression in uterine sarcomas: an immunohistochemical study and review of the literature.
Topics: Benzamides; Endometrial Neoplasms; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Leiomyosarcoma; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma, Endometrial Stromal | 2008 |
Therapy-related acute leukemia with mixed phenotype and t(9;22)(q32;q11.2): a case report and review of the literature.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Back; Benzamides; Bone Marrow; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Cytarabine; Endometrial Neoplasms; Female; Gene Rearrangement; Genes, abl; Humans; Idarubicin; Imatinib Mesylate; Immunophenotyping; Induction Chemotherapy; Karyotyping; Leukemia, Myeloid, Acute; Leukemic Infiltration; Middle Aged; Neoplasms, Second Primary; Piperazines; Pyrimidines; Remission Induction; Soft Tissue Neoplasms; Submandibular Gland Neoplasms; Translocation, Genetic | 2012 |
4 other study(ies) available for imatinib mesylate and Cancer of Endometrium
Article | Year |
---|---|
Imatinib sensitizes endometrial cancer cells to cisplatin by targeting CD117-positive growth-competent cells.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Synergism; Endometrial Neoplasms; Female; Humans; Imatinib Mesylate; Mice; Mice, Inbred BALB C; Middle Aged; Molecular Targeted Therapy; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Random Allocation; Xenograft Model Antitumor Assays | 2014 |
Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.
Topics: Antineoplastic Agents; Benzamides; Carcinoma, Endometrioid; Endometrial Neoplasms; Enzyme Inhibitors; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Paraffin Embedding; Phosphorylation; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptors, Platelet-Derived Growth Factor | 2004 |
KIT-negative undifferentiated endometrial sarcoma with the amplified epidermal growth factor receptor gene showing a temporary response to imatinib mesylate.
Topics: Antineoplastic Agents; Benzamides; Biopsy; Cell Differentiation; DNA, Neoplasm; Endometrial Neoplasms; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma | 2007 |
Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects.
Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Carboplatin; Carcinoma, Papillary; Cell Proliferation; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Humans; Imatinib Mesylate; Immunoenzyme Techniques; Ovarian Neoplasms; Paclitaxel; Piperazines; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; RNA, Messenger; RNA, Neoplasm; Tissue Array Analysis; Tumor Cells, Cultured | 2008 |